News about Biotechnology

India Expands AI-Driven Biotechnology Research across Genomics, Healthcare and Biomanufacturing

The Government of India is advancing AI-driven biotechnology through GenomeIndia, Bio-AI Hubs, IBDC and medical imaging initiatives to boost precision medicine and healthcare.

Biotechnology | 31/07/2026 | By News Bureau

Dr. Jitendra Singh Unveils Phase 3 of Biomedical Research Career Program

Dr. Jitendra Singh launched phase 3 of the Biomedical Research Career Programme (BRCP), backed by DBT and Wellcome Trust, to strengthen India's biomedical workforce and support a USD 300 billion bioeconomy by 2030.

Biotechnology | 16/07/2026 | By News Bureau

Innovent Biologics Licenses Anti-CD40L Therapy IBI355 to Spero Therapeutics in USD 1.1 Billion Deal

Innovent Biologics has licensed global rights outside Greater China for its anti-CD40L antibody IBI355 to Spero Therapeutics in a deal valued at up to USD 1.1 billion, advancing the development of a potential new treatment for autoimmune diseases including IgG4-related disease and Sjögren's disease.

Biotechnology | 15/07/2026 | By News Bureau |  133

Formycon and OneSource Partner to Manufacture Biosimilars

Formycon and OneSource Specialty Pharma have partnered to manufacture biosimilars, with OneSource providing integrated Drug Substance (DS) and Drug Product (DP) manufacturing from its Bengaluru biologics facility.

Biotechnology | 15/07/2026 | By News Bureau

Parexel Launches Biotech Incubator for Early-stage Innovators

Parexel has launched the Parexel Biotech Incubator to support early-stage therapeutics companies with clinical development expertise and strategic resources. The initiative includes a founding partnership with Cape Fear BioCapital to connect incubator to a seed-stage venture partner.

Biotechnology | 24/06/2026 | By News Bureau |  138

India Poised to Become a Global Biopharma Leader: Anupriya Patel

Union Minister Anupriya Patel said India is well-positioned to become a global biopharma leader, highlighting the Biopharma SHAKTI initiative’s goal of launching 100 biologics by 2047. She urged the industry to strengthen capabilities in biologics and biosimilars.

Biotechnology | 12/06/2026 | By News Bureau |  116

Roche and Nurix Partner to Develop BTK Degrader Bexobrutideg

Roche and Nurix Therapeutics have partnered to develop and commercialise bexobrutideg, a potential best-in-class BTK degrader for B-cell malignancies, chronic spontaneous urticaria, and Multiple Sclerosis (MS), aiming to overcome resistance to current BTK inhibitors.

Biotechnology | 09/06/2026 | By News Bureau |  133

Made Scientific and Pluristyx Partner to Advance iPSC Cell Therapies

Made Scientific and Pluristyx have launched a strategic partnership to streamline iPSC-derived cell therapy development and manufacturing. By integrating Pluristyx’s clinical-grade iPSC platform with Made Scientific’s CDMO services, the collaboration provides developers with a single-source pathway from cell line development to commercial supply.

Biotechnology | 08/06/2026 | By News Bureau |  132

Next-generation Nanomedicine can Silence Key Cancer Drivers: Research

Scientists in Pune have developed a next-generation precision nanomedicine that uses gene-silencing technology to target key cancer drivers and effectively inhibit breast tumor growth, highlighting a promising new approach for targeted breast cancer treatment and precision oncology.

Biotechnology | 04/06/2026 | By News Bureau |  112

Illumina Unveils Whole-Genome Sequencing Solution for Sensitive MRD Detection

Illumina has launched the first distributed Whole-Genome Sequencing (WGS) solution for highly sensitive Molecular Residual Disease (MRD) research, enabling faster and more flexible detection of the disease during and after treatment while expanding its next-generation oncology sequencing portfolio.

Biotechnology | 02/06/2026 | By News Bureau |  136